Feasibility of Internet Group CBT-I for Gyn Oncology Patients
Feasibility of Internet-Delivered Group Cognitive Behavioral Therapy for Insomnia in Gynecologic Oncology Patients
1 other identifier
interventional
5
1 country
1
Brief Summary
The goal of this study is to evaluate the feasibility and acceptability of delivering cognitive behavioral therapy for insomnia (CBT-I) to gynecologic cancer patients in an internet-based small-group setting. Secondary objectives:
- 1.To compare insomnia symptoms before and after intervention.
- 2.To evaluate any changes in quality of life symptoms while undergoing the intervention.
- 3.To evaluate the duration of symptoms improvement after the intervention is complete.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2023
CompletedFirst Posted
Study publicly available on registry
September 29, 2023
CompletedStudy Start
First participant enrolled
February 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2024
CompletedJanuary 7, 2025
January 1, 2025
10 months
June 29, 2023
January 3, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Attendance
Main feasibility metric, recorded as number of sessions successfully attended. Participants would need to attend at least 4 sessions of the CBT-I sessions. Therefore, attendance among all participants must be 67% or greater to be considered feasible. A session must be attended for at least 50% of the time or will be counted as missed.
6 weeks
Acceptability
A three-question survey at the end of each session. Question 1 is yes/no, questions 2 and 3 are write in. At the end of the program, a longer acceptability survey will be conducted. If a participant's response to question 1 indicates acceptability for a given session, that session will be deemed 'acceptable'. If 50% or more of participants rated the session as acceptable, then that session will be rated as acceptable.
24 weeks
Secondary Outcomes (3)
Insomnia symptoms
24 weeks
Changes in quality of life symptoms
24 weeks
Sleep Quality
24 weeks
Study Arms (1)
CBT-I online group
EXPERIMENTALTwelve eligible participants will meet weekly for 6 weeks while undergoing the CBT-I program. At the end of each weekly session, participants will complete a survey reviewing the acceptability of undergoing insomnia treatment in an internet-based small-group setting.
Interventions
Eligibility Criteria
You may qualify if:
- English-speaking women greater than 18 years old who present to UC Davis Comprehensive Cancer Center for treatment or surveillance of gynecologic cancer
- Must have access to internet
- Be able to connect via secure web-based platform
- Be able to complete online questionnaires
- Moderate or severe insomnia
- Have access to a mobile device or computer
You may not qualify if:
- Participants without ability to connect with both audio and visual through secure web-based platform
- Participant is currently taking sleep medication prescribed by their provider for sleep disturbance or insomnia - Patients taking over the counter medications or supplements are eligible
- Participants with remote history of insomnia, but not currently having symptoms of insomnia
- Have other reasons for poor sleep
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hui Chen, MD
University of California, Davis
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2023
First Posted
September 29, 2023
Study Start
February 26, 2024
Primary Completion
December 10, 2024
Study Completion
December 10, 2024
Last Updated
January 7, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share